Current and historical daily PE Ratio for Clinical Laserthermia Systems AB (
OSTO:CLS B
) from 2009 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Clinical Laserthermia Systems AB stock (OSTO:CLS B) PE ratio as of Jun 06 2024 is 0.
More Details
Clinical Laserthermia Systems AB (OSTO:CLS B) PE Ratio (TTM) Chart
Clinical Laserthermia Systems AB (OSTO:CLS B) PE Ratio (TTM) Historical Data
View and export this data going back to 2009. Start your Free Trial
Total 1288
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Clinical Laserthermia Systems AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | At Loss | 2024-04-02 | At Loss |
| 2024-06-05 | At Loss | 2024-04-01 | At Loss |
| 2024-06-04 | At Loss | 2024-03-29 | At Loss |
| 2024-06-03 | At Loss | 2024-03-28 | At Loss |
| 2024-05-31 | At Loss | 2024-03-27 | At Loss |
| 2024-05-30 | At Loss | 2024-03-26 | At Loss |
| 2024-05-29 | At Loss | 2024-03-25 | At Loss |
| 2024-05-28 | At Loss | 2024-03-22 | At Loss |
| 2024-05-27 | At Loss | 2024-03-21 | At Loss |
| 2024-05-24 | At Loss | 2024-03-20 | At Loss |
| 2024-05-23 | At Loss | 2024-03-19 | At Loss |
| 2024-05-22 | At Loss | 2024-03-18 | At Loss |
| 2024-05-21 | At Loss | 2024-03-15 | At Loss |
| 2024-05-20 | At Loss | 2024-03-14 | At Loss |
| 2024-05-17 | At Loss | 2024-03-13 | At Loss |
| 2024-05-16 | At Loss | 2024-03-12 | At Loss |
| 2024-05-15 | At Loss | 2024-03-11 | At Loss |
| 2024-05-14 | At Loss | 2024-03-08 | At Loss |
| 2024-05-13 | At Loss | 2024-03-07 | At Loss |
| 2024-05-10 | At Loss | 2024-03-06 | At Loss |
| 2024-05-08 | At Loss | 2024-03-05 | At Loss |
| 2024-05-07 | At Loss | 2024-03-04 | At Loss |
| 2024-05-06 | At Loss | 2024-03-01 | At Loss |
| 2024-05-03 | At Loss | 2024-02-29 | At Loss |
| 2024-05-02 | At Loss | 2024-02-28 | At Loss |
| 2024-04-30 | At Loss | 2024-02-27 | At Loss |
| 2024-04-29 | At Loss | 2024-02-26 | At Loss |
| 2024-04-26 | At Loss | 2024-02-23 | At Loss |
| 2024-04-25 | At Loss | 2024-02-22 | At Loss |
| 2024-04-24 | At Loss | 2024-02-21 | At Loss |
| 2024-04-23 | At Loss | 2024-02-20 | At Loss |
| 2024-04-22 | At Loss | 2024-02-19 | At Loss |
| 2024-04-19 | At Loss | 2024-02-16 | At Loss |
| 2024-04-18 | At Loss | 2024-02-15 | At Loss |
| 2024-04-17 | At Loss | 2024-02-14 | At Loss |
| 2024-04-16 | At Loss | 2024-02-13 | At Loss |
| 2024-04-15 | At Loss | 2024-02-12 | At Loss |
| 2024-04-12 | At Loss | 2024-02-09 | At Loss |
| 2024-04-11 | At Loss | 2024-02-08 | At Loss |
| 2024-04-10 | At Loss | 2024-02-07 | At Loss |
| 2024-04-09 | At Loss | 2024-02-06 | At Loss |
| 2024-04-08 | At Loss | 2024-02-05 | At Loss |
| 2024-04-05 | At Loss | 2024-02-02 | At Loss |
| 2024-04-04 | At Loss | 2024-02-01 | At Loss |
| 2024-04-03 | At Loss | 2024-01-31 | At Loss |
Clinical Laserthermia Systems AB (OSTO:CLS B) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Clinical Laserthermia Systems AB
NAICS : 339112
SIC : 3841
ISIN : SE0022049920
Share Class Description:
OSTO:CLS B: BCompare
Compare
Traded in other countries / regions
CLS B.SwedenLS60.Germany IPO Date
2009-04-16Description
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers